Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
Title:
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
Author:
Hoft, Daniel F. Blazevic, Azra Selimovic, Asmir Turan, Aldin Tennant, Jan Abate, Getahun Fulkerson, John Zak, Daniel E. Walker, Robert McClain, Bruce Sadoff, Jerry Scott, Judy Shepherd, Barbara Ishmukhamedov, Jasur Hokey, David A. Dheenadhayalan, Veerabadran Shankar, Smitha Amon, Lynn Navarro, Garnet Podyminogin, Rebecca Aderem, Alan Barker, Lew Brennan, Michael Wallis, Robert S. Gershon, Anne A. Gershon, Michael D. Steinberg, Sharon